Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Maryland | 900 Studies

Clinical Trials Breast CancerMaryland

Breast Cancer Clinical Trials in Maryland

Find 900 clinical trials for breast cancer near Maryland. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 241-260 of 900 trials

RecruitingAssessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsThis is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are…NCT06418204·Fairbanks, Alaska and 490 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedRO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By SurgeryThis phase I trial studies the side effects and best dose of RO4929097 (gamma-secretase/Notch signalling pathway inhibitor RO4929097) when given together with vismodegib in…NCT01071564·Baltimore, Maryland and 2 others

CompletedEverolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or AnastrozoleThere are no treatments specifically approved after recurrence or progression on a non steroidal aromatase inhibitors (NSAI).NCT00863655·Chandler, Arizona and 199 others

RecruitingPET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBCEligible patients with stage 2 and 3 triple negative breast cancer will be treated with 4 cycles of neoadjuvant paclitaxel/carboplatin/pembrolizumab.NCT06245889·Baltimore, Maryland and 1 other

Active not recruitingFinding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With PaclitaxelThis early phase/phase II trial tests the safety, side effects, and best dose of monosialotetrahexosylganglioside (GM1) and whether it works in reducing or preventing…NCT05751668·Irvine, California and 32 others

RecruitingMetarrestin (ML-246) in Subjects With Metastatic Solid TumorsBackground: Metastasis is the spread of cancer from one organ to a nonadjacent organ. It causes 90% of cancer deaths.NCT04222413·Fairway, Kansas and 1 other

CompletedPANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced CancerBackground: * Many cancers produce two proteins, carcinoembryonic antigen (CEA) and mucin-1 (MUC-1).NCT00088413·Bethesda, Maryland

CompletedDocetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00079170·Bethesda, Maryland

CompletedEvaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)The purpose of this study is to compare the safety and efficacy of nab-paclitaxel in combination with either gemcitabine or carboplatin to the combination of gemcitabine and…NCT01881230·Chandler, Arizona and 139 others

CompletedAn Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast CancerThe purpose of this study is to evaluate the effectiveness and safety of trabectedin in 3 subpopulations of participants with previously treated progressive metastatic ( spread of…NCT00580112·Sedona, Arizona and 32 others

CompletedA Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast CancerThis is a randomized, Phase III, open-label, multicenter study.NCT00789581·Anniston, Alabama and 69 others

TerminatedThe CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerThe purpose of this study is to determine whether maximal estrogen suppression achieved via the combination of an experimental drug, atamestane, plus an FDA-approved drug…NCT00097344·Mobile, Alabama and 103 others

RecruitingA Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerThis study will evaluate the efficacy and safety of inavolisib in combination with Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for subcutaneous use) compared with…NCT05894239·Gilbert, Arizona and 191 others

TerminatedA Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaThe purpose of this phase 2 study is to evaluate the efficacy and safety of NIR178 in combination with PDR001 in multiple solid tumors and diffuse large B-cell lymphoma (DLBCL)…NCT03207867·Santa Monica, California and 20 others

CompletedPhase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerThis Phase 3 clinical study compares the efficacy and safety of elacestrant to the standard of care (SoC) options of fulvestrant or an aromatase inhibitor (AI) in women and men…NCT03778931·Tucson, Arizona and 243 others

CompletedA Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received TrastuzumabThis was a multi-institutional, multinational, open-label, single-arm Phase Ib/II study designed to evaluate the safety, tolerability, pharmacokinetics, and efficacy of…NCT00875979·Boca Raton, Florida and 19 others

CompletedPaclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by SurgeryThis randomized phase II trial studies how well paclitaxel with or without carboplatin and/or bevacizumab followed by doxorubicin and cyclophosphamide works in treating patients…NCT00861705·Jonesboro, Arkansas and 447 others

TerminatedA Pre-Surgical PK Study of IM and Intraductally Delivered FulvestrantThis is an open-label, non-randomized pharmacokinetic study of fulvestrant in women scheduled for mastectomy or lumpectomy.NCT02540330·Baltimore, Maryland and 2 others

CompletedVeliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast CancerThis phase II trial studies how well veliparib with or without carboplatin works in treating patients with stage III or IV breast cancer.NCT01149083·Duarte, California and 22 others

TerminatedTesting the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)This phase II ComboMATCH treatment trial compares the usual treatment alone (fulvestrant) to using binimetinib plus the usual treatment in patients with hormone receptor positive…NCT05554354·Birmingham, Alabama and 195 others

PreviousPage 13 of 45Next

Other Conditions in Maryland

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma